|
Volumn 46, Issue 8, 2002, Pages 1984-1985
|
B cell-ablative therapy for the treatment of autoimmune diseases
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CD20 ANTIGEN;
CYCLOPHOSPHAMIDE;
CYCLOSPORIN A;
IMMUNOGLOBULIN ANTIBODY;
METHOTREXATE;
MONOCLONAL ANTIBODY;
MONOCLONAL ANTIBODY IGG1KAPPA;
RHEUMATOID FACTOR;
STEROID;
TUMOR NECROSIS FACTOR ALPHA ANTIBODY;
UNCLASSIFIED DRUG;
AUTOIMMUNE DISEASE;
B LYMPHOCYTE;
DRUG EFFECT;
DRUG EFFICACY;
DRUG SAFETY;
DRUG TOLERABILITY;
EDITORIAL;
HUMAN;
IDIOPATHIC THROMBOCYTOPENIC PURPURA;
LYMPHOCYTE DEPLETION;
PRIORITY JOURNAL;
SYSTEMIC LUPUS ERYTHEMATOSUS;
ANTIBODIES, MONOCLONAL;
ANTIGENS, CD20;
ARTHRITIS, RHEUMATOID;
AUTOIMMUNE DISEASES;
B-LYMPHOCYTES;
CYTOTOXICITY, IMMUNOLOGIC;
HUMANS;
IMMUNOSUPPRESSION;
|
EID: 0036674876
PISSN: 00043591
EISSN: None
Source Type: Journal
DOI: 10.1002/art.10476 Document Type: Editorial |
Times cited : (30)
|
References (18)
|